Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_assertion type Assertion NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_head.
- NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_assertion description "[Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_provenance.
- NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_assertion evidence source_evidence_literature NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_provenance.
- NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_assertion SIO_000772 17606717 NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_provenance.
- NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_assertion wasDerivedFrom befree-2016 NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_provenance.
- NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_assertion wasGeneratedBy ECO_0000203 NP618165.RAU6jyTrgFDXUlROkE-9p5UxIP2nOzVwbD73sVrZK8tTY130_provenance.